http://www.genengnews.com/news/bnitem.aspx?name=50577314&taxid=39
Research findings suggest there may be a new pathway that controls bone growth through in-vivo and in-vitro that could potentially shield a lot of light on how to effectively treat osteoporosis. The procedure revolves around mesenchymal stem cells with intereron (IFN) gamma that has the the potential to help advance bone growth, which could be extremely valuable to those who suffer from osteoporosis. IFN has been previously been used to keep away infections and to help the immune system fight off illnesses such as cancer.
Although this procedure has the potential to offer help to many people, especially with 1 in 4 women suffering from osteoporosis, the use of stem cells concerning this procedure has been of concern. Even though much more research needs to be done, it has great potential to help many people, and with the high costs of health care this procedure could save a lot of people money who have to spend money on surgeries and procedures due to accidents that happened due to osteoporosis (ex. broken hip, and having to surgery to fix it). With our economy in the horrible recession it's in, this could potentially help a lot of people.
No comments:
Post a Comment